Research statistics

LL-37 research: publications and trials

What has been published on LL-37: PubMed publications, the kind of evidence they report and registered clinical trials. These are counts of research, not a judgment of whether LL-37 works or is safe. For what it is and what the studies found, see the LL-37 profile.
Automated weekly refresh · data through November 8, 2026

At a glance

Publications, all years

2,168

Since 1995

Publications in 2026 so far

125

Through November 8, 2026

Human clinical research

17.3%

375 of 2,164 classified

Registered clinical trials

5

ClinicalTrials.gov

Randomized controlled trials

30

Publications reporting an RCT in people

Systematic reviews and meta-analyses

5

Preclinical studies

73.9%

411 animal · 1,150 in vitro · 38 computational

Records that only mention it

837

Not counted above

Status in the library: Research only. 4 publications are not yet classified by study type.

What to keep in mind

  • More than 70% of the indexed publications are animal, cell or computational studies.
  • Some completed trials have neither posted results nor a linked results publication.
  • The body makes this molecule itself, so much of its literature is physiology rather than research on it as a compound.

Publications by year

LL-37 publications by year and evidence

1995, Preclinical (animal, in vitro, computational): 1 of 11996, Preclinical (animal, in vitro, computational): 1 of 11997, Human clinical research: 1 of 31997, Preclinical (animal, in vitro, computational): 2 of 31998, Preclinical (animal, in vitro, computational): 4 of 41999, Human clinical research: 1 of 61999, Preclinical (animal, in vitro, computational): 4 of 61999, Other and not yet classified: 1 of 62000, Preclinical (animal, in vitro, computational): 9 of 102000, Reviews and meta-analyses: 1 of 102001, Preclinical (animal, in vitro, computational): 9 of 102001, Reviews and meta-analyses: 1 of 102002, Human clinical research: 4 of 172002, Preclinical (animal, in vitro, computational): 12 of 172002, Reviews and meta-analyses: 1 of 172003, Human clinical research: 2 of 242003, Preclinical (animal, in vitro, computational): 18 of 242003, Reviews and meta-analyses: 4 of 242004, Human clinical research: 4 of 282004, Preclinical (animal, in vitro, computational): 20 of 282004, Reviews and meta-analyses: 3 of 282004, Other and not yet classified: 1 of 282005, Human clinical research: 2 of 502005, Preclinical (animal, in vitro, computational): 38 of 502005, Reviews and meta-analyses: 8 of 502005, Other and not yet classified: 2 of 502006, Human clinical research: 3 of 472006, Preclinical (animal, in vitro, computational): 41 of 472006, Reviews and meta-analyses: 1 of 472006, Other and not yet classified: 2 of 472007, Human clinical research: 7 of 432007, Preclinical (animal, in vitro, computational): 31 of 432007, Reviews and meta-analyses: 5 of 432008, Human clinical research: 4 of 532008, Preclinical (animal, in vitro, computational): 43 of 532008, Reviews and meta-analyses: 5 of 532008, Other and not yet classified: 1 of 532009, Human clinical research: 12 of 762009, Preclinical (animal, in vitro, computational): 60 of 762009, Reviews and meta-analyses: 3 of 762009, Other and not yet classified: 1 of 762010, Human clinical research: 11 of 632010, Preclinical (animal, in vitro, computational): 46 of 632010, Reviews and meta-analyses: 5 of 632010, Other and not yet classified: 1 of 632011, Human clinical research: 22 of 902011, Preclinical (animal, in vitro, computational): 65 of 902011, Reviews and meta-analyses: 1 of 902011, Other and not yet classified: 2 of 902012, Human clinical research: 20 of 832012, Preclinical (animal, in vitro, computational): 52 of 832012, Reviews and meta-analyses: 10 of 832012, Other and not yet classified: 1 of 832013, Human clinical research: 11 of 792013, Preclinical (animal, in vitro, computational): 64 of 792013, Reviews and meta-analyses: 4 of 792014, Human clinical research: 35 of 1092014, Preclinical (animal, in vitro, computational): 66 of 1092014, Reviews and meta-analyses: 5 of 1092014, Other and not yet classified: 3 of 1092015, Human clinical research: 22 of 962015, Preclinical (animal, in vitro, computational): 67 of 962015, Reviews and meta-analyses: 6 of 962015, Other and not yet classified: 1 of 962016, Human clinical research: 18 of 962016, Preclinical (animal, in vitro, computational): 70 of 962016, Reviews and meta-analyses: 5 of 962016, Other and not yet classified: 3 of 962017, Human clinical research: 21 of 1042017, Preclinical (animal, in vitro, computational): 76 of 1042017, Reviews and meta-analyses: 4 of 1042017, Other and not yet classified: 3 of 1042018, Human clinical research: 21 of 1142018, Preclinical (animal, in vitro, computational): 89 of 1142018, Reviews and meta-analyses: 3 of 1142018, Other and not yet classified: 1 of 1142019, Human clinical research: 20 of 1102019, Preclinical (animal, in vitro, computational): 84 of 1102019, Reviews and meta-analyses: 5 of 1102019, Other and not yet classified: 1 of 1102020, Human clinical research: 25 of 1342020, Preclinical (animal, in vitro, computational): 92 of 1342020, Reviews and meta-analyses: 13 of 1342020, Other and not yet classified: 4 of 1342021, Human clinical research: 19 of 1182021, Preclinical (animal, in vitro, computational): 89 of 1182021, Reviews and meta-analyses: 9 of 1182021, Other and not yet classified: 1 of 1182022, Human clinical research: 22 of 1372022, Preclinical (animal, in vitro, computational): 104 of 1372022, Reviews and meta-analyses: 9 of 1372022, Other and not yet classified: 2 of 1372023, Human clinical research: 16 of 1052023, Preclinical (animal, in vitro, computational): 81 of 1052023, Reviews and meta-analyses: 6 of 1052023, Other and not yet classified: 2 of 1052024, Human clinical research: 14 of 1042024, Preclinical (animal, in vitro, computational): 77 of 1042024, Reviews and meta-analyses: 12 of 1042024, Other and not yet classified: 1 of 1042025, Human clinical research: 16 of 1282025, Preclinical (animal, in vitro, computational): 101 of 1282025, Reviews and meta-analyses: 10 of 1282025, Other and not yet classified: 1 of 1282026 (to date), Human clinical research: 22 of 1252026 (to date), Preclinical (animal, in vitro, computational): 83 of 1252026 (to date), Reviews and meta-analyses: 19 of 1252026 (to date), Other and not yet classified: 1 of 125Human clinical researchPreclinical (animal, in vitro, computational)Reviews and meta-analysesOther and not yet classified05010015019952002200920162026*
Counted PubMed publications by year of first publication. * 2026 runs to November 8, 2026. A larger bar is more publications, not stronger evidence.
Show the data
YearHuman clinical researchPreclinical (animal, in vitro, computational)Reviews and meta-analysesOther and not yet classifiedTotal
199501001
199601001
199712003
199804004
199914016
2000091010
2001091010
20024121017
20032184024
20044203128
20052388250
20063411247
20077315043
20084435153
200912603176
201011465163
201122651290
2012205210183
201311644079
2014356653109
201522676196
201618705396
2017217643104
2018218931114
2019208451110
20202592134134
2021198991118
20222210492137
2023168162105
20241477121104
202516101101128
2026 (to date)2283191125

Study types

In vitro study1,150
Animal study411
Observational human study296
Review153
Other clinical trial44
Computational study38
Editorial, letter or other32
Randomized controlled trial30
Case report5
Not yet classified4
Meta-analysis3
Systematic review2

Research areas

From MeSH major topics. A paper can be in several areas.

Antimicrobial and infectious disease1,831
Immune system567
Dermatology318
Tissue repair150
Gastrointestinal145
Oncology119
Cardiovascular86
Musculoskeletal60
Reproductive and sexual health53
Metabolic health47
Neurological and mental health46
Endocrinology40

Registered clinical trials

3 of 4 trials completed at least a year before the cutoff have neither posted results nor a linked results publication. A registration is not a result.

Completed: 4 · Unknown status: 1
Phase not applicable: 3 · Phase 1 / Phase 2: 1 · Phase 2: 1

TrialStatusPhaseStartedResults
Peri-implant Vitamin D and Cathelicidin (LL-37) LevelsNCT06867250 · 33 enrolledCompletedPhase not applicable2021-04—
Efficacy of LL-37 Cream on Bacteria Colonization, Inflammation Response and Healing Rate of Diabetic Foot UlcersNCT04098562 · 40 enrolledUnknown statusPhase 22019-10—
Salivary TAS, TOS, LL-37 and Dental Status in Passive Smoking ChildrenNCT04292548 · 180 enrolledCompletedPhase not applicable2016-11—
Intratumoral Injections of LL37 for MelanomaNCT02225366 · 4 enrolledCompletedPhase 1, Phase 22015-07Posted
Effects of Smoking and Vitamin D3 on the Levels of Human Cathelicidin Peptide LL-37NCT03923218 · 60 enrolledCompletedPhase not applicable2011-12—

Human trials and evidence reviews

Meta-analyses, systematic reviews and trials in people, newest first.

  1. Salivary antimicrobial peptides histatin-5, beta defensins, human neutrophilic peptides, LL-37, and calprotectin in severe dental caries, with a focus on early childhood caries: a systematic review and meta-analysis.

    Odontology · June 15, 2026 · Meta-analysis · cited 2 times

    PMID 42295538 · DOI 10.1007/s10266-026-01439-8 · Reviews and meta-analyses

  2. Impact of vitamin D status and cathelicidin antimicrobial peptide on adults with active pulmonary TB globally: A systematic review and meta-analysis.

    PloS one · June 11, 2021 · Meta-analysis · cited 24 times · open access

    PMID 34115790 · DOI 10.1371/journal.pone.0252762 · Reviews and meta-analyses

  3. Transcriptional Profiling of Mycobacterium tuberculosis Exposed to In Vitro Lysosomal Stress.

    Infection and immunity · August 19, 2016 · Meta-analysis · cited 56 times · open access

    PMID 27324481 · DOI 10.1128/iai.00072-16 · Reviews and meta-analyses

  4. Analysis of Antimicrobial Peptide Expression Under Acute and Chronic Alcohol Exposure: A Cross-Sectional Study and a Systematic Review of the Literature.

    International journal of molecular sciences · February 20, 2026 · Systematic review · cited 0 times · open access

    PMID 41752164 · DOI 10.3390/ijms27042026 · Reviews and meta-analyses

  5. Cationic antimicrobial peptides and periodontal physiopathology: A systematic review.

    Journal of periodontal research · June 19, 2019 · Systematic review · cited 40 times

    PMID 31215656 · DOI 10.1111/jre.12676 · Reviews and meta-analyses

  6. Device-Free Auricular Acupressure for Rosacea: A Randomized Clinical Trial.

    JAMA dermatology · October 14, 2026 · Randomized controlled trial · cited 0 times · open access

    PMID 42873508 · DOI 10.1001/jamadermatol.2026.3999 · Human clinical research

  7. Limosilactobacillus fermentum LF61: A multidimensional study on safety and functionality from genomics to clinical application.

    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · February 6, 2026 · Randomized controlled trial · cited 1 times

    PMID 41655688 · DOI 10.1016/j.fct.2026.116002 · Human clinical research

  8. Clinical Safety and Tolerability of <i>Bifidobacterium bifidum</i> BBi32: An 8-Week Randomized, Double-Blind, Placebo-Controlled Trial With Genomic and In Vitro Corroboration.

    Food science & nutrition · January 9, 2026 · Randomized controlled trial · cited 3 times · open access

    PMID 41523287 · DOI 10.1002/fsn3.71420 · Human clinical research

  9. The Immunomodulatory Activity of High Doses of Vitamin D in Critical Care Patients with Severe SARS-CoV-2 Pneumonia-A Randomized Controlled Trial.

    Nutrients · January 31, 2025 · Randomized controlled trial · cited 2 times · open access

    PMID 39940396 · DOI 10.3390/nu17030540 · Human clinical research

  10. Lacticaseibacillus rhamnosus LRa05 in the treatment of acute diarrhea in children: a randomized controlled trial.

    Frontiers in nutrition · November 15, 2024 · Randomized controlled trial · cited 3 times · open access

    PMID 39619284 · DOI 10.3389/fnut.2024.1479186 · Human clinical research

Most cited

By OpenAlex citation count. Citations measure attention, not quality or correctness.

  1. Endogenous antimicrobial peptides and skin infections in atopic dermatitis.

    The New England journal of medicine · October 1, 2002 · In vitro study · cited 1,962 times · open access

    PMID 12374875 · DOI 10.1056/nejmoa021481 · In vitro studies

  2. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide.

    Nature · September 16, 2007 · In vitro study · cited 1,909 times

    PMID 17873860 · DOI 10.1038/nature06116 · In vitro studies

  3. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression.

    Journal of immunology (Baltimore, Md. : 1950) · September 1, 2004 · In vitro study · cited 1,637 times · open access

    PMID 15322146 · DOI 10.4049/jimmunol.173.5.2909 · In vitro studies

  4. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells.

    The Journal of experimental medicine · October 1, 2000 · In vitro study · cited 1,240 times · open access

    PMID 11015447 · DOI 10.1084/jem.192.7.1069 · In vitro studies

  5. Innate antimicrobial peptide protects the skin from invasive bacterial infection.

    Nature · November 1, 2001 · Animal study · cited 1,201 times

    PMID 11719807 · DOI 10.1038/35106587 · Animal studies

Latest publications

  1. Posttranslational Modifications of Unconventional Autoantigens: Shaping Immunogenicity and Inflammatory Activity.

    Immunological reviews · November 1, 2026 · Review · cited 0 times

    PMID 42980169 · DOI 10.1111/imr.70186 · Reviews and meta-analyses

  2. Helicobacter pylori Infection Remodels Neutrophil-Derived Extracellular Vesicles, Promoting Stress and Apoptosis in Infected Epithelial Cells.

    Journal of extracellular vesicles · November 1, 2026 · In vitro study · cited 0 times

    PMID 42976050 · DOI 10.1002/jev2.70388 · In vitro studies

  3. A multifunctional biomimetic hydrogel with antibacterial and antifibrotic properties for scar minimizing repair of infected skin wounds.

    Acta biomaterialia · October 27, 2026 · Animal study · cited 0 times

    PMID 42946320 · DOI 10.1016/j.actbio.2026.10.057 · Animal studies

  4. Association of Porphyromonas gingivalis peptidylarginine deiminase with CitH3, LL-37, and ACPA in periodontitis and rheumatoid arthritis.

    Journal of periodontology · October 27, 2026 · Observational human study · cited 0 times

    PMID 42937026 · DOI 10.1002/jper.70213 · Human clinical research

  5. Device-Free Auricular Acupressure for Rosacea: A Randomized Clinical Trial.

    JAMA dermatology · October 14, 2026 · Randomized controlled trial · cited 0 times · open access

    PMID 42873508 · DOI 10.1001/jamadermatol.2026.3999 · Human clinical research

  6. Topical Remibrutinib Attenuates LL37-Induced Rosacea-Like Dermatitis by Inhibiting BTK Activation, NF-κB Signaling and Mast Cell Activation.

    Journal of inflammation research · October 14, 2026 · Animal study · cited 0 times · open access

    PMID 42894756 · DOI 10.2147/jir.s643728 · Animal studies

  7. LL-37-MRGPRX2-Mast Cell Signaling in Rosacea: Current Evidence and Directions for Human Studies.

    Clinical, cosmetic and investigational dermatology · October 7, 2026 · Review · cited 0 times · open access

    PMID 42861262 · DOI 10.2147/ccid.s648503 · Reviews and meta-analyses

  8. Full-length brain-derived α-synuclein fibril models reveal fuzzy-coat control of peptide recognition.

    Protein science : a publication of the Protein Society · October 1, 2026 · Computational study · cited 0 times · open access

    PMID 42742050 · DOI 10.1002/pro.70782 · Computational studies

  9. Coordination chemistry and antimicrobial activity of LL-37, its C-terminal fragment, and a peptidomimetic analogue.

    Dalton transactions (Cambridge, England : 2003) · September 29, 2026 · In vitro study · cited 0 times · open access

    PMID 42708248 · DOI 10.1039/d6dt01638c · In vitro studies

  10. Association of Vitamin D Supplementation with VDR and CAMP Expression and Ulcer Healing in Diabetic Foot Infection Involving Biofilm-Forming Bacteria: An Exploratory Prospective Cohort Study.

    Pharmaceuticals (Basel, Switzerland) · September 23, 2026 · Other clinical trial · cited 0 times · open access

    PMID 42943205 · DOI 10.3390/ph19101508 · Human clinical research

Browse all 2,168 publications in the dashboard

How this is counted

PubMed records matched by the names below, counted when the peptide is in the title, indexed by MeSH, or confirmed from the abstract. The exact query can be rerun on Europe PMC. Methodology

Search terms: hCAP-18; Human cathelicidin; LL37

((TITLE_ABS:"hCAP-18" OR CHEM:"hCAP-18" OR TITLE_ABS:"hCAP18" OR CHEM:"hCAP18") OR (TITLE_ABS:"Human cathelicidin" OR CHEM:"Human cathelicidin") OR (TITLE_ABS:"LL37" OR CHEM:"LL37" OR TITLE_ABS:"LL 37" OR CHEM:"LL 37")) AND SRC:MED

Cite this page

Peptide Library. (2026, November 9). LL-37 research statistics (Version weekly-2026-11-08) [Statistic]. Peptide Library. https://peptidelibrary.app/research/peptides/ll-37